Seres Therapeutics Inc.

NASDAQ: MCRB · Real-Time Price · USD
7.00
0.00 (0.00%)
At close: Jun 03, 2025, 3:59 PM
7.31
4.43%
After-hours: Jun 03, 2025, 06:06 PM EDT
0.00%
Bid 6.7
Market Cap 61.13M
Revenue (ttm) n/a
Net Income (ttm) 72.95M
EPS (ttm) -7.95
PE Ratio (ttm) -0.88
Forward PE -0.87
Analyst Hold
Ask 7.52
Volume 127,977
Avg. Volume (20D) 89,496
Open 7.10
Previous Close 7.00
Day's Range 6.98 - 7.41
52-Week Range 6.53 - 30.60
Beta 2.88

About MCRB

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol MCRB
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for MCRB stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
3 weeks ago
-16.04%
Seres Therapeutics shares are trading lower after ... Unlock content with Pro Subscription
5 months ago
+3.83%
Seres Therapeutics shares are trading higher after the company announced that SER-155 received FDA breakthrough therapy designation for its bloodstream infection reduction.